Change in hbA1c following treatment with and the short-term risk of major adverse cardiovascular outcomes

Back

ESC Professional Premium Access

Change in hbA1c following treatment with and the short-term risk of major adverse cardiovascular outcomes

Session: Diabetes and the heart (1)

Topic: Diabetes and the Heart

Speaker: Mrs B. Zareini (Copenhagen, DK)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Mrs Bochra Zareini

Nordsjaellands Hospital, Copenhagen (Denmark)

0 follower

6 more presentations in this session

Effect of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on markers of neurohumoral activation and left atrial strain.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Cardioprotective pharmacotherapy in patients with type 2 diabetes across the Middle East and Africa: the PACT-MEA study

Speaker: Professor S. Verma (Toronto, CA)

Access

Abstract

Slides

Incident cardiovascular disease in women with type 1 or type 2 diabetes by history of hypertensive disorders of pregnancy

Speaker: Associate Professor S. Timpka (Malmo, SE)

The prognostic value of high-sensitivity cardiac troponin t in diabetes patients without coronary artery disease

Speaker: Mr Y. He (Guangzhou, CN)

Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Access the full session

Diabetes and the heart (1)

Speakers: Mrs B. Zareini, Doctor I. Ikonomidis, Professor S. Verma, Associate Professor S. Timpka, Mr Y. He...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources